1 / 100

Drug Overdose (DO) Overview

Drug Overdose (DO) Overview. September, 2006 Intensive Care Unit United Christian Hospital. DO Evaluation. Motive (intentional Vs incidental) Co-morbidity Related Drug Time of exposure and presentation Co-ingestion Other poison, corrosives exposure/ injury Symptoms & Vital Signs (VS).

brede
Télécharger la présentation

Drug Overdose (DO) Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Drug Overdose (DO) Overview September, 2006 Intensive Care Unit United Christian Hospital

  2. DO Evaluation • Motive (intentional Vs incidental) • Co-morbidity • Related Drug • Time of exposure and presentation • Co-ingestion • Other poison, corrosives exposure/ injury • Symptoms & Vital Signs (VS)

  3. DO Evaluation • Co-morbidity CVS: HT, IHD, arrhythmia, CHF Resp: Chronic respiratory insufficiency Renal: CRF GI: liver impairment, chronic hepatitis Alcoholism Drug addiction

  4. DO Evaluation • Related Drug 1.Types (e.g.salicylates, CCB) 2.Amount (e.g. dose, concentration) 3.Single Vs Multiple dose 4.Formula, preparation e.g. liquid, dispersible, enteric-coated, sustained-release, IV 5.Time of exposure and presentation

  5. DO Evaluation • Co-ingestion: (Maybe >2 agents) 1.paracetamol + salicylates 2.paracetamol + opioids 3.alcohol + paracetamol 4.alcohol + sedatives • Other poison, corrosives exposure/ injury 1.Carbon monoxide 2.Dettol 3.Bleaching agents 4.通渠水

  6. DO Evaluation • Symptoms (Toxidrome: Toxicologic Syndrome) NEJM Volume 355:602-611 August 10, 2006 Number 6

  7. DO Evaluation • Hypothermia ethanol, sedatives, barbiturates, hypoglycaemics, opioids, carbon monoxide beta-blockers (BB) • Hyperthermia Cocaine, amphetamines, neuroleptics, anticholinergics, lithium, salicylates, sympathomimetics

  8. DO Evaluation • Hypotension CCB, BB, antihypertensives, barbiturates,TCA, opioids, ethanol, theophylline, diuretics • Hypertension Amphetamine, cocaine, sympathomimetics, MAOI, anticholinergics, phenothiazines

  9. DO Evaluation • Hyperventilation Amphetamine, cocaine, anticholinergics, ethanol, methaemoglobin inducers, salicylates, theophylline, isoniazid • Hypoventilation Barbiturates, opioids, colchicine, ethanol, sedative-hypnotics, TCA

  10. DO Evaluation • Bradycardia CCB, BB, digoxin, opioids • Tachycardia Amphetamine, cocaine, anticholinergics, sympathomimetics, theophylline, TCA

  11. DO Evaluation • Bedside blood glucose test • SpO2 • ECG • Serum chemistry blood gas, electrolytes (e.g. Na, K, iCa2+) R//LFT • CBP, clotting profile • Drug level • Toxicology screen (blood, urine, gastric fluid) • CXR/AXR

  12. Management • A,B,C • GI Tract Decontamination • Enhance Elimination • Antidotes

  13. GI Tract Decontamination • Emesis • Orogastric Lavage • Activated Charcoal • Whole Bowel Irrigation

  14. Emesis Seldom use, have Risk • Acute ingestion of potentially toxic substance ( < 1hr) • Only potentially useful in pre-hospital setting with long transport time to medical care

  15. Orogastric Lavage (GL) • Large-bore fenestrated orogastric tube (36-40 Fr) • Require protected airway • Amount of poison ingested is potentially life threatening • Within 60 minutes of ingestion (Except anti-cholinergic < 12 hr ingestion; salicylate < 24 hr ingestion)

  16. Orogastric Lavage • Contraindications: Caustic/ Corrosive ingestion Large foreign bodies or sharp objects Airway not protected Suspected UGI injury Hypoxia

  17. Activated Charcoal (AC) • One gram of activated carbon has the surface area (>400 m2) of approximately two tennis courts (260 m2) ! • Single Dose • Multiple Dose

  18. Activated Charcoal (AC) • Used in: 1. Enterohepatic Circulation: Digoxin, amitriptyline, phenobarbitone, dozepin 2. Theophylline, salicylates

  19. Activated Charcoal (AC) • Not bind well to: Lithium, strong acids and bases, and most inorganic minerals (examples of these are sodium, iron, lead), Alcohol (such as ethanol, methanol, isopropyl alcohol, and glycols), ammonia

  20. Single Dose AC • ~1 gram/ Kg • Adult dose: 60 to 90grams

  21. Multiple Dose AC • Phenobarbital, dapsone, theophylline, digoxin, phyentoin, carbamazepine, aspirin • SR products, Enteric-coated product, Concretion formation • Enterohepatic circulation, low proetin-binding, long half-life • Dose: 0.5g/kg Q2-6H (till “charcoal stools” and also depending on D.O. severity)

  22. AC Contraindications • I.O. • Ileus • GI perforation • Loss of airway protection

  23. Whole Bowel Irrigation (WBI) • mechanically flushing the ingestedpoison out of the gastrointestinal tract before it can be absorbed into the body • iso-osmolar solution of polyethylene glycol • Rate:1-2L per hour (minimally) • P.O. or R/T • Entire procedure usually takes 4 to 6 hours • Till rectal effluent clear

  24. Whole Bowel Irrigation (WBI) • Indicatios: • potentially toxic ingestion of substance that not well-absorbed by activated charcoal (e.g. Fe, Li, Pb, Zn) • Sustained release/ Enteric coasted preparation • Rising drug level despite GL/AC

  25. Whole Bowel Irrigation (WBI) • Contraindications: I.O. Ileus GI perforation GIB Compromised airway

  26. Enhance Elimination • Urinary alkalinization • Saline diuresis • Haemodialysis and haemoperfusion

  27. Urinary alkalinization • By ion trapping mechanism • Urine pH >7.5 • Method: Stat 1-2mEq/kg of NaHCO3 Continuous infusion NaHCO3 in D5 e.g. 1LD5+NaHCO3 150mmol+ 40mmol KCl Q8H Monitor serum pH, avoid >7.55 Maintain normokalaemia

  28. Urinary alkalinization • Salicylates • Methotrexate • Chlorpropamide • Phenobarbital

  29. Saline diuresis • Saline diuresis NOT equal to Forced diuresis • Forced diuresis: use diuretics to increase urinary elimination of toxin—generally NOT helpful • Saline diuresis For lithium

  30. Antidotes • Acetaminophen N-acetylcysteine • Benzodiazepine Flumazenil • Beta blockers Glucagon • Calcium blockers Calcium • Iron or Aluminum Deferroxamine • Isonizide (INH) Vit B6 • Methemoglobinemia Methylene bluce • Methanol Alcohol • Opioid Naloxone • TCA anti-depressants Sodium bicarbonate • Coumarin Vit K1

  31. Haemodialysis and haemoperfusion • Drug HD HP • Aspirin D* D • Lithium D/MD unknown • Phenobarbital D/MD D • Theophylline D D

  32. Haemodialysis and haemoperfusion • Not Useful in TCA Digoxin Valporic acid Dilantin

  33. Drug Overdose • Antipyretic & Analgesic • Antidepressants • Cardiovascular Medications • “Sleeping Pills” • Antipsychotics, Neuroleptics & Mood Stabilizers • Hypoglycaemic Agents • Anticonvulsants

  34. Antipyretic & Analgesic • Paracetamol • Salicylates • Non-Steroidal Anti-Inflammatory Drugs (NSAID)

  35. Case 1 • 28/F worked as clerk • Non-drinker Thin-built • Suicidal D.O. • Claimed took 10 tab panadol + 40 tab 靈芝丸at 03:00 attended AED 13:00 • Panadol level at 13:00 >150mcg/ml • NAC started, developed rash, so stopped NAC temporally , given anti-histamine and resumed NAC at slower rate

  36. Case 1 • INR 1.5--1.7-- > 2 AST rising trend • pH Normal • INR still on rising trend • AST > 3000 (peak) • Transferred to QMH liver transplant team • Responsive to medical Rx

  37. Paracetamol

  38. Paracetamol Only • Acetaminophen • Tylenol, Tempra, Datril (USA) • Panadol (UK, HK) 必理痛 • Progesic • Fortolin幸福止痛素

  39. Medications with Paracetamol • Saridon 散利痛 250mg paracetamol+65mg caffeine • Dologesic 325mg paracetamol+32.5mg dextropropoxyphene • Coltalin-ND, Coltalin cold tabs 幸福傷風素 325mg paracetamol+phenylephrine+chlorpheniramine, etc

  40. Paracetamol • International Union of Pure and Applied Chemistry (IUPAC) name: N-(4-hydroxyphenyl)acetamide Other chemical names: N-acetyl-para-aminophenol and para-acetyl-amino- phenol APAP • Chemical Formula: C8H9NO2

  41. Paracetamol • Pharmacokinetic data Absorption a) Peak serum levels i. 1-2hrs at therapeutic dose ii. 2-4hrs in overdose Bioavailability almost 100% Low protein binding

  42. Paracetamol • Metabolism (therapeutic dose): 90-95% hepatic t1/2: 2-3hrs in therapeutic doses 1. >90% non-toxic sulfate & glucuronide conjugates 2.<5% by cytochrome P450 2E1 to N-acetyl-para-benzoquinoneimine (NAPQI), strong oxidizing agent NAPQI is reduced by glutathione into non-toxic mercaptate conjugate

  43. Paracetamol • Metabolism (Overdose) 90-95% hepatic t1/2: prolonged in overdose 1. non-toxic sulfate & glucuronide conjugates pathway(Saturated) 2. Increase in NAPQI, depletes glutathione stores-->NAPQI accumulates-->hepatocellular centribular necrosis and renal injury

  44. Paracetamol • Factors favor NAPQI toxic pathway a) Enzyme inducers: smoking, barbiturates, phenytoin, INH, alcohol, carbamazepine b) Reduced glutathione stores: malnutrition, alcoholism, fasting, HIV, chronic disease, long-term use of paracetamol

  45. Paracetamol Overdose • Clinical presentation • Toxic dose >150mg/kg ; massive overdose >1g/kg Phase 1 (0.5-24h) minimal symptoms; metabolic acidosis in massive overdose Phase 2 (24-72h) RUQ pain, elevation of hepatic enzymes. 25% of hepatotoxic patients have impaired renal function Phase 3 (72-96h) marked hepatic dysfunction including hepatic encephalopathy. Death is related to hepatic failure Phase 4 (4-14 days) resolution of hepatic dysfunction

  46. Paracetamol Overdose Evaluation • History: Time of ingestion Amount ingested (150mg/kg potentially toxic) • Serum level: 4hrs post-ingestion/ as soon as possible thereafter Nomogram -Without NAC, 60% of those with initial drug level above toxic line will have aminotransferase > 1000IU/L

  47. Rumack and Matthew (Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics. 1975;55:871-876.)

  48. Treatment of Paracetamol D.O. • Gastric lavage Consider only for coingestants • Activated charcoal Only of benefit within 4 hours of ingestion 1gm/kg • N-acetylcysteine (NAC) Protection of NAC is 100% if given within 8 hrs of ingestion

  49. N-acetylcysteine (NAC) • Mechanism: Precursor for glutathione Increase non-toxic sulfation metabolism Prevent covalent binding of NAPQI to hepatocytes • Dose: (Load)150mg/ kg in 200ml-500ml D5 over 15min to 1 hr (then)50mg/kg in 500ml D5 over 4 hrs (then)100mg/kg in 1L D5 over 16 hrs

  50. N-acetylcysteine (NAC) • Paracetamol level above treatment line • All patients with potentially hepatotoxic overdose (> 150 mg/kg). Treatment can be stopped if paracetamol concentration is below standard treatment line (Level taken >/=4hr of ingestion & not extended release type) • All paracetamol ingestions who present late (>24 hours) with either detectable serum paracetamol or elevated tansaminases • All patients with evidence of severe toxicity or fulminant hepatic failure, regardless of time since overdose. Continue or start NAC 150mg/kg/day until recovery from encephalopathy or patient dies • Chronic large ingestions (>4g/day in adult), especially those who are high risk and deranged LFT

More Related